LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

FDA recall notice · announced June 8, 2016 · Invisiblu

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

Reason for recall

Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033

Notes

Distribution: Nationwide and Brazil.
Lot/code information: Lot # 21511166, Exp 11/18
Quantity: 3,319 bottles
Status: Ongoing
Products in this recall event:
- LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL (D-0910-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.